Akoustis Technologies Inc (AKTS)

$0.04 0.00 (-9.05%)
Market Cap 5.75M
Revenue (ttm) 27.38M
Net Income (ttm) -167.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -613.40%
Debt to Equity Ratio 0.00
Volume 118,703,398
Avg Vol 26,170,799
Day's Range N/A - N/A
Shares Out 154.59M
Stochastic %K 6%
Beta 1.91
Analysts Sell
Price Target $1.00

Company Profile

Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells radio frequency (RF) filter products for the wireless industry in the Americas, Asia, Europe, and internationally. It operates in two segments, Fabrication Services and RF Filters. The Fabrication Services segment provides engineering review and backend packaging services. The RF Filters segment sells amplifier and filter products. It offers RF filters for the wireless industry, such a...

Industry: Communication Equipment
Sector: Technology
Phone: 704 997 5735
Fax: 704 997 5734
Address:
9805 Northcross Center Court, Suite A, Huntersville, United States
RadioIsotope25
RadioIsotope25 Feb. 3 at 2:56 PM
Why RADX’s B7-H3 can upend Aktis Oncology’s in 2026… $AKTS $RADX $CATX
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 3 at 1:01 AM
$RADX https://assets.kpmg.com/content/dam/kpmgsites/uk/pdf/2024/12/leveraging-opportunities-in-radiopharm.pdf $AKTS RADX $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 2 at 3:21 PM
Why radiopharmaceuticals are becoming central to precision oncology $RADX $AKTS $CATX https://www.drugtargetreview.com/article/192528/why-radiopharmaceuticals-are-becoming-central-to-precision-oncology/
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 2 at 2:49 PM
$RADX CATX just raised $179 million this morning. Radiopharm is simmering $CATX $AKTS
0 · Reply
Billonstart
Billonstart Jan. 30 at 8:14 PM
$AKTS We need patience to make money.
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 29 at 11:43 PM
$RADX $AKTS https://youtu.be/AAoayfujeFs
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 28 at 3:21 PM
$RADX Upside in Aktis is $4 billion equals 300%. Their market cap is $1 billion already they have the halo ipo valuation. Upside in Radiopharm Theranostics is minimum $200-500 million could be $1 to 2 billion. At $60 million market cap you calculate the upside. $AKTS $LNTH
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 28 at 2:45 AM
RADX vs AKTS $60 million vs $1 billion $RADX $AKTS
3 · Reply
RadioIsotope25
RadioIsotope25 Jan. 27 at 2:58 PM
Alpha- vs Beta-Radiopharmaceuticals Impact Immune Checkpoints Differently $AKTS $RADX $CATX https://bioengineer.org/alpha-vs-beta-radiopharmaceuticals-impact-immune-checkpoints-differently/
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 26 at 10:50 PM
$AKTS Nice reversal today
0 · Reply
Latest News on AKTS
Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jan 13, 2026, 6:30 AM EST - 22 days ago

Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO

Jan 9, 2026, 10:05 PM EST - 25 days ago

U.S. IPO Weekly Recap: Aktis Oncology Leads As First Sizable 2026 IPO

Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets

Jan 9, 2026, 12:58 PM EST - 25 days ago

Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets

LLY

Aktis Oncology prices upsized US IPO at $18 per share

Jan 8, 2026, 9:20 PM EST - 26 days ago

Aktis Oncology prices upsized US IPO at $18 per share

Aktis Oncology Announces Pricing of its Upsized Initial Public Offering

Jan 8, 2026, 8:48 PM EST - 26 days ago

Aktis Oncology Announces Pricing of its Upsized Initial Public Offering

Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies

Jan 6, 2026, 11:50 AM EST - 4 weeks ago

Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies

U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week

Jan 2, 2026, 10:35 PM EST - 4 weeks ago

U.S. IPO Weekly Recap: Small Issuers And SPACs Join The Pipeline In Short Holiday Week

APC BTGO EQPT GRAY IBL KLK LIFE

Aktis Oncology files for US IPO as biotech listings rebound

Dec 19, 2025, 5:51 PM EST - 6 weeks ago

Aktis Oncology files for US IPO as biotech listings rebound

Phase 1 solid tumor biotech Aktis Oncology files for a $100 million IPO

Dec 19, 2025, 5:51 PM EST - 6 weeks ago

Phase 1 solid tumor biotech Aktis Oncology files for a $100 million IPO

Aktis Oncology IPO Registration Document (S-1)

Dec 19, 2025, 4:02 PM EST - 6 weeks ago

Aktis Oncology IPO Registration Document (S-1)

RadioIsotope25
RadioIsotope25 Feb. 3 at 2:56 PM
Why RADX’s B7-H3 can upend Aktis Oncology’s in 2026… $AKTS $RADX $CATX
1 · Reply
RadioIsotope25
RadioIsotope25 Feb. 3 at 1:01 AM
$RADX https://assets.kpmg.com/content/dam/kpmgsites/uk/pdf/2024/12/leveraging-opportunities-in-radiopharm.pdf $AKTS RADX $CATX
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 2 at 3:21 PM
Why radiopharmaceuticals are becoming central to precision oncology $RADX $AKTS $CATX https://www.drugtargetreview.com/article/192528/why-radiopharmaceuticals-are-becoming-central-to-precision-oncology/
0 · Reply
RadioIsotope25
RadioIsotope25 Feb. 2 at 2:49 PM
$RADX CATX just raised $179 million this morning. Radiopharm is simmering $CATX $AKTS
0 · Reply
Billonstart
Billonstart Jan. 30 at 8:14 PM
$AKTS We need patience to make money.
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 29 at 11:43 PM
$RADX $AKTS https://youtu.be/AAoayfujeFs
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 28 at 3:21 PM
$RADX Upside in Aktis is $4 billion equals 300%. Their market cap is $1 billion already they have the halo ipo valuation. Upside in Radiopharm Theranostics is minimum $200-500 million could be $1 to 2 billion. At $60 million market cap you calculate the upside. $AKTS $LNTH
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 28 at 2:45 AM
RADX vs AKTS $60 million vs $1 billion $RADX $AKTS
3 · Reply
RadioIsotope25
RadioIsotope25 Jan. 27 at 2:58 PM
Alpha- vs Beta-Radiopharmaceuticals Impact Immune Checkpoints Differently $AKTS $RADX $CATX https://bioengineer.org/alpha-vs-beta-radiopharmaceuticals-impact-immune-checkpoints-differently/
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 26 at 10:50 PM
$AKTS Nice reversal today
0 · Reply
Billonstart
Billonstart Jan. 26 at 6:13 AM
$AKTS It is Great company. It will go to the moon.
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 23 at 11:37 PM
Radiopharmaceuticals are on the rise as drug developers realize enormous potential | TRACER $RADX $AKTS https://www.tracercro.com/resources/blogs/radiopharmaceuticals-are-on-the-rise-as-drug-developers-realize-enormous-potential/
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 23 at 12:27 PM
$AKTS sorry was for $AKTX **************
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 23 at 12:26 PM
$AKTS need to make a change to u * creating issues for the other stocksso will move u out the way
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 22 at 8:37 PM
$AKTS $RADX $CATX
0 · Reply
cor1
cor1 Jan. 22 at 6:11 PM
$RADX $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 22 at 5:51 PM
$BCYC is a similar comparable to $RADX and their valuation is 8x and $AKTS is 20x…
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 22 at 5:39 PM
En Fuego $AKTS $RADX
0 · Reply
3thefischer
3thefischer Jan. 22 at 10:51 AM
$AKTS I had a 20K possision which i liquidated early 2025 f0r 200Bucks 🫠
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 21 at 11:52 PM
Rad101 shows tumors that MRI’s can’t. 300,000 patient population.. would be 3rd largest revenue radiopharmaceutical imaging agent in world. $RADX $LNTH $AKTS
0 · Reply
RadioIsotope25
RadioIsotope25 Jan. 21 at 6:43 PM
$RADX Re: Lantheus- 20:24 from Conf today; Uh they are the largest investor with 15% of the company, Um they don’t have a board seat. They don’t have first right of refusal. So they play the investor roles. They are a five billion dollar company. So they are looking at our products and I am sure they are interested in many of them. Our job is to advance and prove products can be successful and potentially that collaboration can go. $LNTH $AKTS
1 · Reply
RadioIsotope25
RadioIsotope25 Jan. 21 at 3:42 PM
Radiopharm Theranostics, Ltd. (NASDAQ: $RADX) (ASX: RAD) - YouTube $AKTS $IBRX $IOVA $LNTH https://www.youtube.com/watch?v=XVL6708YTvU
1 · Reply